Publication | Closed Access

Effect of apalutamide on health-related quality of life in patients with non-metastatic castration-resistant prostate cancer: an analysis of the SPARTAN randomised, placebo-controlled, phase 3 trial

Quality Of LifeUrologyHealth-related QualityMedicineCancer ManagementClinical TrialsPatient-reported OutcomePharmacotherapyProstatic DiseaseOncologyRadiation OncologyHealth Sciences